BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 34527405)

  • 1. Comparison of two regional citrate anticoagulation modalities for continuous renal replacement therapy by a prospective analysis of safety, workload, effectiveness, and cost.
    Cassina T; Villa M; Soldani-Agnello A; Zini P
    Minerva Anestesiol; 2021 Dec; 87(12):1309-1319. PubMed ID: 34527405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Safety and efficacy of regional citrate anticoagulation in continuous renal replacement therapy in the presence of acute kidney injury after hepatectomy].
    Zhang C; Lin T; Zhang J; Liang H; Di Y; Li N; Gao J; Wang W; Liu S; Wang Z; Jiang H; Liu C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Aug; 30(8):777-782. PubMed ID: 30220281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution.
    Morabito S; Pistolesi V; Tritapepe L; Zeppilli L; Polistena F; Strampelli E; Pierucci A
    Crit Care; 2012 Jun; 16(3):R111. PubMed ID: 22738289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Customized Citrate Anticoagulation versus No Anticoagulant in Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: A Prospective Randomized Controlled Trial.
    Ratanarat R; Phairatwet P; Khansompop S; Naorungroj T
    Blood Purif; 2023; 52(5):455-463. PubMed ID: 36858026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different modalities of continuous renal replacement therapy with regional sodium citrate anticoagulation in paediatric patients.
    He J; Xiao Z; Zhou X; Cao J; Kang X; Zhang X
    Int J Artif Organs; 2022 Dec; 45(12):997-1005. PubMed ID: 35903018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy: An Observational Study.
    Bianchi NA; Altarelli M; Eckert P; Schneider AG
    Blood Purif; 2020; 49(5):567-575. PubMed ID: 32126564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid-base status and phosphate supplementation needs.
    Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
    BMC Nephrol; 2013 Oct; 14():232. PubMed ID: 24156306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional citrate anticoagulation in predilution continuous venovenous hemofiltration using prismocitrate 10/2 solution.
    Shum HP; Chan KC; Yan WW
    Ther Apher Dial; 2012 Feb; 16(1):81-6. PubMed ID: 22248200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional citrate anticoagulation versus no-anticoagulation for continuous venovenous hemofiltration in patients with liver failure and increased bleeding risk: A retrospective case-control study.
    Yu Y; Bai M; Ma F; Zhang W; Li Y; Zhao L; Li L; Zhou M; Li L; Sun S
    PLoS One; 2020; 15(5):e0232516. PubMed ID: 32369523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a Protocol for Continuous Hemodiafiltration with Regional Citrate Anticoagulation with Omni®.
    Whiting L; Bianchi NA; Alouazen K; Joannes-Boyau O; Chiche JD; Schneider A
    Blood Purif; 2022; 51(12):1039-1047. PubMed ID: 35636389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional citrate anticoagulation versus low molecular weight heparin anticoagulation for continuous venovenous hemofiltration in patients with severe hypercalcemia: a retrospective cohort study.
    Yu Y; Bai M; Wei Z; Zhao L; Li Y; Ma F; Sun S
    Ren Fail; 2020 Nov; 42(1):748-758. PubMed ID: 32718221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD).
    Mitchell A; Daul AE; Beiderlinden M; Schäfers RF; Heemann U; Kribben A; Peters J; Philipp T; Wenzel RR
    Clin Nephrol; 2003 Feb; 59(2):106-14. PubMed ID: 12608553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation.
    Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
    Int J Artif Organs; 2013 Dec; 36(12):845-52. PubMed ID: 24362894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant effect of low concentration plasma trisodium citrate in continuous veno-venous hemofiltration.
    Long J; Li Z; Zhang Z; Dong X; Zhu C
    Ann Palliat Med; 2021 Aug; 10(8):8900-8908. PubMed ID: 34488377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF).
    Hofmann RM; Maloney C; Ward DM; Becker BN
    Ren Fail; 2002 May; 24(3):325-35. PubMed ID: 12166699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citrate anticoagulation in plasma exchange followed by continuous renal replacement therapy in critically ill children.
    Xinping Z; Jie H; Zhenya Y; Desheng Z; Xiong Z
    Int J Artif Organs; 2024 Feb; 47(2):85-95. PubMed ID: 38229209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A continuous veno-venous hemofiltration protocol with anticoagulant citrate dextrose formula A and a calcium-containing replacement fluid.
    Ong SC; Wille KM; Speer R; Tolwani AJ
    Int J Artif Organs; 2014 Jun; 37(6):499-502. PubMed ID: 24811309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous venovenous hemofiltration with or without predilution regional citrate anticoagulation: a prospective study.
    Nurmohamed SA; Vervloet MG; Girbes AR; Ter Wee PM; Groeneveld AB
    Blood Purif; 2007; 25(4):316-23. PubMed ID: 17700015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparison between Two Dilute Citrate Solutions (15 vs. 18 mmol/l) in Continuous Renal Replacement Therapy: The Base Excess and Renal Substitution Solution Study.
    Anstey C; Campbell V; Richardson A
    Blood Purif; 2016; 42(3):194-201. PubMed ID: 27352175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.